Elizabeth A. Fagan
- Effect of pirfenidone on treatment-emergent (TE) all-cause mortality (ACM) in patients with idiopathic pulmonary fibrosis (IPF): Pooled data analysis from ASCEND and CAPACITYBy Steven D. Nathan, Carlo Albera, Williamson Z. Bradford, Ulrich Costabel, Roland M. du Bois, Elizabeth A. Fagan, Ian Glaspole, Marilyn K. Glassberg, David Kardatzke, Talmadge E. King, Klaus-Uwe Kirchgaessler, Lisa H. Lancaster, David J. Lederer, Carlos A. Pereira, Jeffrey J. Swigris, Dominique Valeyre and Paul W. NobleSteven D. Nathan1Lung Transplant Program, Inova Fairfax Hospital, Falls Church, VA United StatesCarlo Albera2Clinical and Biological Sciences, University of Turin, Turin, ItalyWilliamson Z. Bradford3Intermune, Brisbane, CA United StatesUlrich Costabel4Pneumology and Allergy, Ruhrlandklinik, Essen, GermanyRoland M. du Bois5Respiratory Medicine, Imperial College, London, United KingdomElizabeth A. Fagan3Intermune, Brisbane, CA United StatesIan Glaspole6Interstitial Lung Disease Unit, Alfred Hospital and Monash University, Melbourne, AustraliaMarilyn K. Glassberg7Medicine and Surgery, University of Miami Miller School of Medicine, Miami, FL United StatesDavid Kardatzke3Intermune, Brisbane, CA United StatesTalmadge E. King Jr.8Medicine, University of California - San Francisco, San Francisco, CA United StatesKlaus-Uwe Kirchgaessler9Roche, Basel, SwitzerlandLisa H. Lancaster10Medicine, Vanderbilt University Medical Center, Nahville, TN United StatesDavid J. Lederer11Lung Transplant Program, Columbia University, New York, United StatesCarlos A. Pereira12Paulista School of Medicine, Federal University of São Paulo, São Paulo, BrazilJeffrey J. Swigris13Medicine, National Jewish Health, Denver, CO United StatesDominique Valeyre14Assistance Publique-Hôpitaux de Paris, Avicenne University, Bobigny, FrancePaul W. Noble15Medicine, Cedars-Sinai Hospital, Los Angeles, CA United States
- Pirfenidone for idiopathic pulmonary fibrosis: analysis of pooled data from three multinational phase 3 trialsBy Paul W. Noble, Carlo Albera, Williamson Z. Bradford, Ulrich Costabel, Roland M. du Bois, Elizabeth A. Fagan, Robert S. Fishman, Ian Glaspole, Marilyn K. Glassberg, Lisa Lancaster, David J. Lederer, Jonathan A. Leff, Steven D. Nathan, Carlos A. Pereira, Jeffrey J. Swigris, Dominique Valeyre and Talmadge E. KingArticle | Published in 2015 in European Respiratory JournalPaul W. Noble1Cedars-Sinai Medical Center, Los Angeles, CA, USACarlo Albera2University of Turin, Turin, ItalyWilliamson Z. Bradford3InterMune Inc., Brisbane, CA, USAUlrich Costabel4Ruhrlandklinik, University of Duisburg-Essen, Essen, GermanyRoland M. du Bois5Imperial College, London, UKElizabeth A. Fagan3InterMune Inc., Brisbane, CA, USARobert S. Fishman3InterMune Inc., Brisbane, CA, USAIan Glaspole6Alfred Hospital and Monash University, Melbourne, AustraliaMarilyn K. Glassberg7University of Miami Miller School of Medicine, Miami, FL, USALisa Lancaster8Vanderbilt University Medical Center, Nashville, TN, USADavid J. Lederer9Columbia University Medical Center, New York, NY, USAJonathan A. Leff3InterMune Inc., Brisbane, CA, USASteven D. Nathan10Inova Fairfax Hospital, Falls Church, VA, USACarlos A. Pereira11Paulista School of Medicine, Federal University of São Paulo, São Paulo, BrazilJeffrey J. Swigris12National Jewish Health, Denver, CO, USADominique Valeyre13Assistance Publique-Hôpitaux de Paris, Avicenne University Hospital, Bobigny, FranceTalmadge E. King Jr14University of California, San Francisco, San Francisco, CA, USA
- Pirfenidone for idiopathic pulmonary fibrosis: analysis of pooled data from three multinational phase 3 trialsBy Paul W. Noble, Carlo Albera, Williamson Z. Bradford, Ulrich Costabel, Roland M. du Bois, Elizabeth A. Fagan, Robert S. Fishman, Ian Glaspole, Marilyn K. Glassberg, Lisa Lancaster, David J. Lederer, Jonathan A. Leff, Steven D. Nathan, Carlos A. Pereira, Jeffrey J. Swigris, Dominique Valeyre and Talmadge E. KingPaul W. Noble1Cedars-Sinai Medical Center, Los Angeles, CA, USACarlo Albera2University of Turin, Turin, ItalyWilliamson Z. Bradford3InterMune Inc., Brisbane, CA, USAUlrich Costabel4Ruhrlandklinik, University of Duisburg-Essen, Essen, GermanyRoland M. du Bois5Imperial College, London, UKElizabeth A. Fagan3InterMune Inc., Brisbane, CA, USARobert S. Fishman3InterMune Inc., Brisbane, CA, USAIan Glaspole6Alfred Hospital and Monash University, Melbourne, AustraliaMarilyn K. Glassberg7University of Miami Miller School of Medicine, Miami, FL, USALisa Lancaster8Vanderbilt University Medical Center, Nashville, TN, USADavid J. Lederer9Columbia University Medical Center, New York, NY, USAJonathan A. Leff3InterMune Inc., Brisbane, CA, USASteven D. Nathan10Inova Fairfax Hospital, Falls Church, VA, USACarlos A. Pereira11Paulista School of Medicine, Federal University of São Paulo, São Paulo, BrazilJeffrey J. Swigris12National Jewish Health, Denver, CO, USADominique Valeyre13Assistance Publique-Hôpitaux de Paris, Avicenne University Hospital, Bobigny, FranceTalmadge E. King Jr14University of California, San Francisco, San Francisco, CA, USA
Buying books on this site
Purchases made on this website are of electronic books only.
About the ERS books
The ERS Monograph is the quarterly book series from the European Respiratory Society. Each Monograph covers a specific area of respiratory medicine, providing in-depth reviews that give clinicians at all levels a concise, comprehensive guide to symptoms, diagnosis and treatment.
The ERS Handbooks are compact guides to broad areas of the respiratory field. Launched in 2010, the series now covers adult, paediatric and sleep respiratory medicine, and a companion volume of self-assessment questions is available. In 2015, the first ERS Practical Handbook, on Noninvasive Ventilation, was added to the series
